Is the US Military Secretly Under Chinese Control?

From Investing Trends | Ad

Alarmingly, the answer may be "yes". Communist China now controls 80% of the lithium that powers most US military vehicles and equipment. The threat level is so high that the White House recently declared a state of emergency on lithium...

Discover How To Invest in Lithium Mining

LGND Insider Trading (Ligand Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.70%

Insider Buying (Last 12 Months): $206,900.00

Insider Selling (Last 12 Months): $3,363,464.96

Ligand Pharmaceuticals Insider Trading History Chart

Ligand Pharmaceuticals Share Price & Price History

^$91.06

▲ +4.33 (4.99%)

As of 05/17/2022 01:31 PM ET

Days: 30 | 90 | 365

The Incredible Dividend Map... Where Stocks Yield 26% a Year!

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

Ligand Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/13/2022	Matthew W. Foehr	COO	Buy	2,500	$82.76	$206,900.00	173,354
2/28/2022	John W Kozarich	Director	Sell	908	$102.62	$93,178.96
11/12/2021	John L. Higgins	CEO	Sell	3,000	$160.50	$481,500.00
11/11/2021	Matthew W. Foehr	COO	Sell	11,160	$163.02	$1,819,303.20
8/4/2021	Matthew W. Foehr	COO	Sell	8,840	$109.67	$969,482.80	173,195
2/10/2021	Todd C Davis	Director	Sell	5,083	$213.14	$1,083,390.62	47,678
2/4/2021	Charles S Berkman	SVP	Sell	18,097	$178.50	$3,230,314.50	47,003
2/4/2021	Matthew W. Foehr	COO	Sell	44,547	$176.86	$7,878,582.42	167,198
1/27/2021	John L. Higgins	CEO	Sell	40,000	$182.00	$7,280,000.00	285,310
1/25/2021	John L. Higgins	CEO	Sell	50,000	$159.00	$7,950,000.00	285,310
8/24/2020	Matthew W. Foehr	COO	Sell	78	$110.89	$8,649.42	155,413
8/21/2020	Matthew W. Foehr	COO	Sell	7,225	$112.88	$815,558.00	155,413
6/4/2020	Charles S Berkman	SVP	Sell	11,146	$118.59	$1,321,804.14	40,877
2/27/2020	Matthew W. Foehr	COO	Buy	7,225	$14.47	$104,545.75	160,968
2/27/2020	Matthew W. Foehr	COO	Buy	1,706	$21.92	$37,395.52	155,449
2/27/2020	Matthew W. Foehr	COO	Sell	7,225	$110.00	$794,750.00	160,968
2/15/2020	Matthew W. Foehr	COO	Sell	869	$97.23	$84,492.87	155,360
2/15/2020	Matthew W. Foehr	COO	Sell	447	$97.23	$43,461.81	154,913
2/15/2020	Matthew W. Foehr	COO	Sell	1,170	$97.23	$113,759.10	153,743
2/14/2020	Matthew W. Foehr	COO	Buy	7,225	$14.47	$104,545.75	163,454
2/14/2020	Matthew W. Foehr	COO	Sell	7,225	$95.84	$692,444.00	148,833
2/13/2020	Matthew W. Foehr	COO	Buy	496	$21.92	$10,872.32	148,833
2/13/2020	Matthew W. Foehr	COO	Buy	7,396	$0.00	$0.00	156,229
9/3/2019	Jason Aryeh	Director	Buy	750	$87.01	$65,257.50	67,203
8/5/2019	Jason Aryeh	Director	Buy	746	$90.01	$67,147.46	66,453
8/2/2019	Sunil Patel	Director	Buy	1,000	$95.98	$95,980.00	26,359
7/31/2019	Jason Aryeh	Director	Buy	4,004	$99.22	$397,276.88	61,953
7/31/2019	John L. Higgins	CEO	Buy	1,850	$95.45	$176,582.50	146,749
7/29/2019	Jason Aryeh	Director	Buy	250	$106.01	$26,502.50	61,953
6/11/2019	Jason Aryeh	Director	Buy	250	$107.01	$26,752.50	61,703
5/31/2019	Jason Aryeh	Director	Buy	1,000	$109.51	$109,510.00	59,868
5/29/2019	Jason Aryeh	Director	Buy	250	$111.01	$27,752.50	59,868
5/20/2019	Jason Aryeh	Director	Buy	250	$112.01	$28,002.50	59,618

The Incredible Dividend Map... Where Stocks Yield 26% a Year!

From Investing Daily | Ad

Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

96.61% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ligand Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/17/2022	Eaton Vance Management	5,686	$0.64M	0.0%	-5.8%	0.034%
5/17/2022	First Republic Investment Management Inc.	3,696	$0.42M	0.0%	-25.8%	0.022%
5/16/2022	California State Teachers Retirement System	20,604	$2.32M	0.0%	-7.6%	0.122%
5/16/2022	Goldman Sachs Group Inc.	53,859	$6.06M	0.0%	-38.7%	0.319%
5/16/2022	State Street Corp	1,091,793	$122.82M	0.0%	-90.6%	6.475%
5/16/2022	Orchard Capital Managment LLC	73,596	$8.28M	2.4%	+7.3%	0.436%
5/16/2022	Invesco Ltd.	194,566	$21.89M	0.0%	-6.9%	1.154%
5/16/2022	UBS Group AG	31,284	$3.52M	0.0%	+16.4%	0.186%
5/16/2022	Granahan Investment Management LLC	9,063	$1.02M	0.0%	-86.9%	0.054%
5/16/2022	Hsbc Holdings PLC	4,034	$0.46M	0.0%	+207.0%	0.024%
5/13/2022	Northern Trust Corp	202,214	$22.75M	0.0%	-14.4%	1.199%
5/13/2022	Charles Schwab Investment Management Inc.	154,481	$17.38M	0.0%	+0.8%	0.916%
5/13/2022	Edgestream Partners L.P.	17,718	$1.99M	0.2%	-33.1%	0.105%
5/13/2022	Lazard Asset Management LLC	886	$99K	0.0%	-100.0%	0.005%
5/13/2022	First Trust Advisors LP	7,949	$0.89M	0.0%	+86.2%	0.047%
5/13/2022	Prudential Financial Inc.	17,395	$1.96M	0.0%	-1.6%	0.103%
5/13/2022	Federated Hermes Inc.	6,847	$0.77M	0.0%	-25.5%	0.041%
5/13/2022	American International Group Inc.	8,765	$0.99M	0.0%	-5.7%	0.052%
5/13/2022	Vanguard Group Inc.	1,727,638	$194.34M	0.0%	+0.6%	10.247%
5/13/2022	Sei Investments Co.	2,616	$0.30M	0.0%	-80.3%	0.016%
5/13/2022	Blair William & Co. IL	12,303	$1.38M	0.0%	-18.1%	0.073%
5/13/2022	Dimensional Fund Advisors LP	378,118	$42.54M	0.0%	+1.5%	2.243%
5/12/2022	Yousif Capital Management LLC	15,834	$1.78M	0.0%	+1.4%	0.094%
5/12/2022	BlackRock Inc.	2,733,307	$307.47M	0.0%	-45.5%	16.211%
5/12/2022	Rhumbline Advisers	46,027	$5.18M	0.0%	+2.3%	0.273%
5/12/2022	Metropolitan Life Insurance Co NY	996	$0.11M	0.0%	-75.4%	0.006%
5/12/2022	MetLife Investment Management LLC	8,617	$0.97M	0.0%	+54.9%	0.051%
5/12/2022	Northeast Financial Consultants Inc	2,755	$0.31M	0.0%	+46.9%	0.016%
5/12/2022	E Fund Management Co. Ltd.	2,399	$0.27M	0.0%	N/A	0.014%
5/11/2022	Investment Management of Virginia LLC	37,246	$4.19M	0.7%	-16.8%	0.221%
5/11/2022	Bank of New York Mellon Corp	184,068	$20.71M	0.0%	-73.4%	1.092%
5/11/2022	William Blair Investment Management LLC	914,099	$102.83M	0.3%	-34.7%	5.421%
5/11/2022	State of Tennessee Treasury Department	11,057	$1.24M	0.0%	+18.9%	0.066%
5/11/2022	Jupiter Asset Management Ltd.	15,914	$1.79M	0.0%	-1.8%	0.094%
5/10/2022	ProShare Advisors LLC	5,154	$0.58M	0.0%	-16.5%	0.031%
5/10/2022	PAX Financial Group LLC	3,968	$0.45M	0.1%	N/A	0.024%
5/9/2022	GW&K Investment Management LLC	34,873	$3.92M	0.0%	+36.7%	0.207%
5/9/2022	Principal Financial Group Inc.	122,416	$13.77M	0.0%	-6.5%	0.726%
5/9/2022	Swiss National Bank	39,500	$4.44M	0.0%	+7.6%	0.234%
5/9/2022	Teacher Retirement System of Texas	3,433	$0.39M	0.0%	+4.8%	0.020%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	1,505	$0.17M	0.0%	+11.6%	0.009%
5/9/2022	Qube Research & Technologies Ltd	7,459	$0.84M	0.0%	N/A	0.044%
5/6/2022	Smith Graham & Co. Investment Advisors LP	86,834	$9.77M	1.0%	-0.6%	0.515%
5/6/2022	Texas Permanent School Fund	11,848	$1.33M	0.0%	-1.7%	0.070%
5/5/2022	Rice Hall James & Associates LLC	344,969	$38.81M	1.6%	-0.8%	2.046%
5/5/2022	New York State Common Retirement Fund	10,935	$1.23M	0.0%	-1.9%	0.065%
5/4/2022	Advisor Group Holdings Inc.	1,341	$0.15M	0.0%	+10.6%	0.008%
5/4/2022	Stephens Investment Management Group LLC	417,670	$46.98M	0.7%	+1.5%	2.477%
5/4/2022	Stephens Inc. AR	1,886	$0.21M	0.0%	-11.0%	0.011%
5/4/2022	Isthmus Partners LLC	14,720	$1.66M	0.3%	+7.9%	0.087%
5/4/2022	Victory Capital Management Inc.	33,869	$3.43M	0.0%	+27.4%	0.201%
5/4/2022	Envestnet Asset Management Inc.	23,528	$2.65M	0.0%	+9.0%	0.140%
5/4/2022	abrdn plc	335,003	$37.68M	0.1%	-7.6%	1.987%
5/2/2022	Mutual of America Capital Management LLC	2,407	$0.27M	0.0%	+5.4%	0.014%
4/29/2022	SG Americas Securities LLC	5,699	$0.64M	0.0%	-33.0%	0.034%
4/28/2022	TownSquare Capital LLC	4,299	$0.48M	0.0%	+19.2%	0.026%
4/28/2022	DekaBank Deutsche Girozentrale	4,540	$0.53M	0.0%	+9.7%	0.027%
4/27/2022	Comerica Bank	14,257	$1.47M	0.0%	+1.6%	0.085%
4/27/2022	AMI Asset Management Corp	42,551	$4.79M	0.3%	+5.2%	0.252%
4/25/2022	Welch & Forbes LLC	3,925	$0.44M	0.0%	N/A	0.023%
4/21/2022	Oregon Public Employees Retirement Fund	6,262	$0.70M	0.0%	-3.1%	0.037%
4/21/2022	Chicago Capital LLC	491,717	$55.31M	2.4%	+12.7%	2.918%
4/21/2022	Inspire Investing LLC	6,891	$0.78M	0.1%	N/A	0.041%
4/21/2022	Inspire Advisors LLC	4,247	$0.48M	0.1%	N/A	0.025%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	2,348	$0.26M	0.0%	+9.4%	0.014%
4/20/2022	Harbor Investment Advisory LLC	623	$70K	0.0%	+18.2%	0.004%
4/19/2022	Villere ST Denis J & Co. LLC	510,843	$57.46M	3.4%	-1.6%	3.031%
4/14/2022	State of Alaska Department of Revenue	11,628	$1.31M	0.0%	-1.7%	0.069%
4/11/2022	Nordea Investment Management AB	72,343	$8.46M	0.0%	+1.3%	0.429%
4/7/2022	Woodstock Corp	64,050	$7.21M	0.8%	-6.7%	0.380%
3/9/2022	Norges Bank	122,456	$18.92M	0.0%	N/A	0.727%
2/19/2022	William Blair Investment Management LLC	1,400,341	$216.30M	0.6%	+1.8%	8.379%
2/18/2022	Comerica Bank	14,032	$1.64M	0.0%	-7.2%	0.084%
2/17/2022	Goldman Sachs Group Inc.	87,876	$13.57M	0.0%	+45.6%	0.526%
2/16/2022	The Manufacturers Life Insurance Company	7,654	$1.18M	0.0%	-3.2%	0.046%
2/16/2022	California State Teachers Retirement System	22,305	$3.45M	0.0%	+2.3%	0.133%
2/16/2022	Orchard Capital Managment LLC	68,596	$10.60M	3.1%	+1.9%	0.410%
2/16/2022	Parametric Portfolio Associates LLC	69,329	$10.71M	0.0%	-3.8%	0.415%
2/16/2022	State of Tennessee Treasury Department	9,300	$1.44M	0.0%	-1.9%	0.056%
2/16/2022	Wasatch Advisors Inc.	195,197	$30.15M	0.1%	-9.7%	1.168%
2/16/2022	Thrivent Financial for Lutherans	13,600	$2.10M	0.0%	+0.9%	0.081%
2/15/2022	Stephens Investment Management Group LLC	411,359	$63.54M	0.8%	+0.3%	2.461%
2/15/2022	Penserra Capital Management LLC	7,317	$1.13M	0.0%	+1,825.5%	0.044%
2/15/2022	Amalgamated Bank	7,757	$1.20M	0.0%	-1.7%	0.046%
2/15/2022	Public Employees Retirement System of Ohio	324	$50K	0.0%	+34.4%	0.002%
2/15/2022	Advisors Asset Management Inc.	9,035	$1.40M	0.0%	+27.8%	0.054%
2/15/2022	Sei Investments Co.	13,255	$2.04M	0.0%	-13.3%	0.079%
2/15/2022	Kennedy Capital Management Inc.	10,815	$1.67M	0.0%	-3.4%	0.065%
2/15/2022	Legal & General Group Plc	46,997	$7.26M	0.0%	+3.2%	0.281%
2/15/2022	Cubist Systematic Strategies LLC	3,116	$0.48M	0.0%	+48.0%	0.019%
2/14/2022	Virtus ETF Advisers LLC	2,598	$0.40M	0.2%	-30.0%	0.016%
2/14/2022	Squarepoint Ops LLC	1,307	$0.20M	0.0%	-70.2%	0.008%
2/14/2022	Point72 Asset Management L.P.	54,100	$8.36M	0.0%	N/A	0.324%
2/14/2022	Rice Hall James & Associates LLC	347,699	$53.71M	1.9%	-7.0%	2.081%
2/14/2022	Impax Asset Management Group plc	134,820	$20.82M	0.1%	+35.7%	0.807%
2/14/2022	Alliancebernstein L.P.	25,239	$3.90M	0.0%	-8.3%	0.151%
2/14/2022	Credit Suisse AG	22,784	$3.52M	0.0%	-9.4%	0.136%
2/14/2022	LPL Financial LLC	3,176	$0.49M	0.0%	+4.7%	0.019%
2/14/2022	Goldman Sachs Group Inc.	87,876	$13.57M	0.0%	+45.6%	0.526%
2/14/2022	Nuveen Asset Management LLC	55,445	$7.71M	0.0%	-7.1%	0.332%

Data available starting January 2016

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; and Nexterone, a captisol-enabled formulation of amiodarone; and Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners and licenses programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver and kidney disease, and other diseases. Further, it sells Captisol materials. The company was incorporated in 1987 and is headquartered in Emeryville, California.

Today's Range

Now: $91.06

$88.35

$91.06

50 Day Range

MA: $102.80

$78.68

$120.80

52 Week Range

Now: $91.06

$77.80

$169.98

Volume

1,554 shs

Average Volume

163,104 shs

Market Capitalization

$1.54 billion

P/E Ratio

65.99

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top insider investors include:
John L Higgins (CEO)
Matthew W Foehr (COO)
Todd C Davis (Director)
Charles S Berkman (SVP)
John W Kozarich (Director)
Learn More about top insider investors at Ligand Pharmaceuticals.
Who are the major institutional investors of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top institutional investors include:
BlackRock Inc. — 16.21%
Vanguard Group Inc. — 10.25%
State Street Corp — 6.48%
William Blair Investment Management LLC — 5.42%
Villere ST Denis J & Co. LLC — 3.03%
Chicago Capital LLC — 2.92%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.
Which institutional investors are selling Ligand Pharmaceuticals stock?: In the previous quarter, LGND stock was sold by these institutional investors:
Lazard Asset Management LLC
State Street Corp
BlackRock Inc.
Bank of New York Mellon Corp
William Blair Investment Management LLC
Granahan Investment Management LLC
Northern Trust Corp
Goldman Sachs Group Inc.
During the previous year, company insiders that have sold Ligand Pharmaceuticals company stock include:
John L Higgins (CEO)
Matthew W Foehr (COO)
Todd C Davis (Director)
Learn More investors selling Ligand Pharmaceuticals stock.
Which institutional investors are buying Ligand Pharmaceuticals stock?: During the previous quarter, LGND stock was acquired by institutional investors including:
Chicago Capital LLC
Vanguard Group Inc.
GW&K Investment Management LLC
Qube Research & Technologies Ltd
Victory Capital Management Inc.
Inspire Investing LLC
Stephens Investment Management Group LLC
Dimensional Fund Advisors LP

How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.